Production (Stage)
Synaptogenix, Inc.
SNPX
$2.42
$0.167.08%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -42.52% | 54.30% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -50.92% | 60.23% | |||
| Operating Income | 50.92% | -60.23% | |||
| Income Before Tax | 106.94% | 3.40% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 106.94% | 3.40% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 106.94% | 3.40% | |||
| EBIT | 50.92% | -60.23% | |||
| EBITDA | 50.95% | -60.34% | |||
| EPS Basic | 102.91% | 9.07% | |||
| Normalized Basic EPS | 114.59% | 56.21% | |||
| EPS Diluted | 100.96% | 9.07% | |||
| Normalized Diluted EPS | 114.51% | 56.21% | |||
| Average Basic Shares Outstanding | 2.09% | 2.83% | |||
| Average Diluted Shares Outstanding | 2.62% | 2.83% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | 1.00% | |||